Molecular monitoring of BCR–ABL as a guide to clinical management in chronic myeloid leukaemia
To access this article, please choose from the options below
PII: S0268-960X(05)00009-3
doi:10.1016/j.blre.2005.01.008
© 2005 Elsevier Ltd. All rights reserved.
